Sab Biotherapeutics, Inc.
SABS
Revenue
263.14k
▼-681.44k▼-72.14%
3 Months ChangeAssets
61.89M
▼-9.48M▼-13.28%
3 Months ChangeLiabilities
15.77M
▼-2.78M▼-14.97%
3 Months ChangeFree Cash Flow
-10.88M
▼-9.25M▼-568.65%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-09
Form 8-K
ID: 0000950170-24-104564
2024-08-08
Form 10-Q
ID: 0000950170-24-094084
2024-07-31
Form 8-K
ID: 0000950170-24-088247
2024-06-27
Form 8-K
ID: 0000950170-24-078622
2024-05-31
Form 8-K
ID: 0000950170-24-066856
2024-05-21
Form 8-K
ID: 0000950170-24-062656
2024-05-20
Form 10-Q
ID: 0000950170-24-062367
2024-05-08
Form 8-K
ID: 0000950170-24-054868
2024-04-15
Form 8-K
ID: 0000950170-24-044497
2024-03-29
Form 8-K
ID: 0000950170-24-038429